Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures
Phase 3
Completed
- Conditions
- Anesthesia, Dental
- First Posted Date
- 2006-03-31
- Last Posted Date
- 2006-11-17
- Lead Sponsor
- Novalar Pharmaceuticals, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT00309335
- Locations
- 🇺🇸
Tufts University School of Dental Medicine, Boston, Massachusetts, United States
Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing Procedures
Phase 2
Completed
- Conditions
- Anesthesia, Dental
- First Posted Date
- 2006-03-31
- Last Posted Date
- 2006-11-17
- Lead Sponsor
- Novalar Pharmaceuticals, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT00309322
- Locations
- 🇺🇸
The Forsyth Institute, Boston, Massachusetts, United States
Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Mandibular Procedures
Phase 3
Completed
- Conditions
- Anesthesia, Dental
- First Posted Date
- 2006-03-31
- Last Posted Date
- 2006-11-17
- Lead Sponsor
- Novalar Pharmaceuticals, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT00309361
- Locations
- 🇺🇸
Tufts School of Dental Medicine, Boston, Massachusetts, United States
Safety and Efficacy Study of NV-101 in Dental Patients
Phase 2
Completed
- Conditions
- Soft Tissue Anesthesia (Numbness)
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2005-09-14
- Lead Sponsor
- Novalar Pharmaceuticals, Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT00154167
- Locations
- 🇺🇸
Northwest Kinetics, Tacoma, Washington, United States